Cardiome Pharma Corp. (NASDAQ: CRME) is pleased to announce that it has moved one step closer to launching XYDALBA in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE